Biogen Partners with Capsigen on AAV Capsids

By Michelle Liu

Pharma Deals Review: Vol 2021 Issue 6 (Table of Contents)

Published: 17 Jun-2021

DOI: 10.3833/pdr.v2021.i6.2611     ISSN: 1756-7874

Section: Research & Development



Continuing its push into gene therapies, Biogen has agreed to partner with Capsigen to engineer adeno-associated virus capsids to deliver gene therapies for various CNS and neuromuscular disease targets...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details